Aesthetik Engineers LimitedAESTHETIKCorporate

Latest results: Mar 2026 6 quarters of data

—

MCap —

Live price not available

Aesthetik Engineers Limited — Stock analysis & AI research Aesthetik Engineers Limited — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹80 Cr

Sales · Mar 2026

+100.0% YoY

₹6 Cr

Operating Profit · Mar 2026

-14.3% YoY

7.5%

OPM % · Mar 2026

-57.1% YoY

₹4 Cr

Net Profit · Mar 2026

-20.0% YoY

₹2.10

EPS · Mar 2026

-26.8% YoY

📝 Aesthetik Engineers Limited — results explained

Quarter ended March 2026 (Q4 FY26)

Aesthetik Engineers Limited reported revenue of ₹80 crore for the quarter ended March 2026 (Q4 FY26), up 100.0% from ₹40 crore in the same quarter last year.

Net profit fell 20.0% year-on-year to ₹4 crore, from ₹5 crore. Earnings per share (EPS) came in at ₹2.10.

Operating profit stood at ₹6 crore — an operating margin (OPM) of 7.5%, compared with 17.5% in the year-ago quarter.

Full year and trailing twelve months

On a trailing-twelve-month (TTM) basis, revenue stands at ₹118 crore with a net profit of ₹8 crore.

Shareholding pattern

As of Mar 2026, promoters held 69.57%, foreign institutional investors (FIIs) 0.00%, domestic institutional investors (DIIs) 0.09%, public shareholders 29.78% of Aesthetik Engineers Limited.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

N/A

Current Price ?

N/A

P/E ?

N/A

Industry P/E ?

N/A

P/B ?

N/A

P/S ?

N/A

P/FCF ?

N/A

Enterprise Value ?

N/A

EV/EBITDA ?

N/A

PEG ?

N/A

Earnings Yield ?

N/A

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹118 Cr

OPM ?

10.2%

Profit after tax (TTM) ?

₹8 Cr

EPS (TTM) ?

₹4.31

ROCE ?

18.0%

ROE ?

16.0%

ROA ?

8.7%

Growth

Sales — latest qtr ?

₹80 Cr

PAT — latest qtr ?

₹4 Cr

YoY qtr sales growth ?

100.0%

YoY qtr profit growth ?

-20.0%

Sales growth (3y) ?

43%

Sales growth (5y) ?

N/A

Profit growth (3y) ?

85%

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹25 Cr

Debt to Equity ?

0.50

Interest Coverage ?

N/A

Current Ratio ?

N/A

Ownership

Promoter holding ?

69.57%

Change in promoter holding ?

0.03%

Pledged percentage ?

N/A

Market

Return 3 months ?

N/A

Return 6 months ?

N/A

🗓️ Quarterly results (6 quarters · ₹ Cr)

same fiscal quarter as Mar bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Sep 2025	Mar 2026	YoY %	QoQ %
Sales	22	39	26	40	38	80	+100.0%	—
Operating Profit	2	6	1	7	6	6	-14.3%	—
Other Income	0	0	0	1	0	1	+0.0%	—
Interest	0	0	0	1	1	1	+0.0%	—
Depreciation	0	0	0	1	1	1	+0.0%	—
Profit Before Tax	1	5	1	7	5	5	-28.6%	—
Net Profit	1	4	1	5	4	4	-20.0%	—
EPS	13.27	3.07	0.39	2.87	2.03	2.10	-26.8%	—
OPM %	9.1%	15.4%	3.8%	17.5%	15.8%	7.5%	-57.1%	—

📆 Annual results (₹ Cr, FY = Apr–Mar)

Annual rollup not yet available We need at least 3 quarters of a fiscal year to compute annual figures. This symbol does not yet have a complete fiscal year in our database.

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	0.84	13	17	17	+0.0%
Reserves	9	2	27	33	+22.2%
Borrowings	6	8	10	25	+150.0%
Other Liabilities	9	7	9	17	+88.9%
Total Liabilities	25	31	63	92	+46.0%
Fixed Assets	4	4	14	26	+85.7%
CWIP	0	0	0	0	—
Investments	0	0	6	6	+0.0%
Other Assets	21	27	43	60	+39.5%
Total Assets	25	31	63	92	+46.0%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	3	-2	3	15	+400.0%
Cash from Investing Activity	-1	1	-21	-13	+38.1%
Cash from Financing Activity	-2	2	20	-2	-110.0%
Net Cash Flow	-0	1	2	0	-100.0%
Free Cash Flow	3	-3	-8	3	+137.5%
CFO/OP	178%	-19%	45%	152%	+237.8%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	66	30	104	54	-48.1%
Inventory Days	53	92	74	102	+37.8%
Days Payable	48	40	45	44	-2.2%
Cash Conversion Cycle	70	81	133	111	-16.5%
Working Capital Days	9	58	104	48	-53.8%
ROCE %	—	37%	21%	18%	-14.3%

👥 Shareholding (latest 4 periods)

Metric	Sep 2024	Mar 2025	Sep 2025	Mar 2026	% Chg
Promoters	69.54%	69.54%	69.57%	69.57%	+0.0%
FIIs	2.76%	0.03%	0.00%	0.00%	—
DIIs	3.77%	1.24%	0.09%	0.09%	+0.0%
Public	23.93%	29.19%	30.34%	29.78%	-1.8%
Others	0.00%	0.00%	0.00%	0.56%	—
No. of Shareholders	1,065	1,078	742	785	+5.8%

⚖️ Peer comparison

Peer comparison unavailablePeer comparison unavailable — industry and sector are not classified for this symbol.

❓ Frequently asked questions

What was Aesthetik Engineers Limited's revenue in Q4 FY26?